Schipper J, Berlis A, Klenzner T, Schramm A, Gellrich NC, Rosahl S, Maier W. Navigationsunterstützte tumorfokussierte Chirurgie bei Schädelbasismalignomen.
HNO 2007;
55:465-71. [PMID:
17160663 DOI:
10.1007/s00106-006-1466-8]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
BACKGROUND
Multimodal strategies are required due to the poor prognosis for locally advanced frontal skull base tumors staged as T4. Therefore, a further increase in the degree of invalidity caused by therapy should be avoided, if possible, to preserve the quality of life. As the incidence of these tumors is low, there are no evidence-based, generally accepted therapeutic strategies.
METHODS
We evaluated the clinical results of three patients with extended frontal skull base malignomas staged as T4 tumors. The clinical course as well as the surgical technique were analyzed.
RESULTS
High dose neoadjuvant therapy for tumor downsizing was performed in all three patients within a multimodal therapy concept. The additional space for surgical manipulation close to the tumor borders, non-traumatically produced by tumor remission, permitted a safely navigated, controlled resection of the tumor under endoscopic or microscopic viewing using an approach associated with reduced trauma as "targeted surgery".
CONCLUSIONS
Surgical radicality is limited by the direct vicinity of locally progressive T4 tumors to the frontal brain and other vital structures. A controlled tumor downsizing allows the resection of such tumors using a minimally invasive approach assisted by instrumental navigation leading to less traumatization.
Collapse